143 related articles for article (PubMed ID: 37011915)
1. Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones.
Singh AK; Kim SM; Oh JM; Abdelgawad MA; Ghoneim MM; Rangarajan TM; Kumar S; Sudevan ST; Trisciuzzi D; Nicolotti O; Kim H; Mathew B
Chem Biol Drug Des; 2023 Aug; 102(2):271-284. PubMed ID: 37011915
[TBL] [Abstract][Full Text] [Related]
2. Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: Fluorinated chalcones of morpholine versus imidazole.
Mathew B; Baek SC; Thomas Parambi DG; Lee JP; Mathew GE; Jayanthi S; Vinod D; Rapheal C; Devikrishna V; Kondarath SS; Uddin MS; Kim H
Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800309. PubMed ID: 30663112
[TBL] [Abstract][Full Text] [Related]
3. Selected 1,3-Benzodioxine-Containing Chalcones as Multipotent Oxidase and Acetylcholinesterase Inhibitors.
Jeong GS; Kaipakasseri S; Lee SR; Marraiki N; Batiha GE; Dev S; Palakkathondi A; Kavully FS; Gambacorta N; Nicolotti O; Mathew B; Kim H
ChemMedChem; 2020 Dec; 15(23):2257-2263. PubMed ID: 32924264
[TBL] [Abstract][Full Text] [Related]
4. Assembling a Cinnamyl Pharmacophore in the C3-Position of Substituted Isatins via Microwave-Assisted Synthesis: Development of a New Class of Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease.
Manoharan A; Oh JM; Benny F; Kumar S; Abdelgawad MA; Ghoneim MM; Shaker ME; El-Sherbiny M; Almohaimeed HM; Gahtori P; Kim H; Mathew B
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630420
[TBL] [Abstract][Full Text] [Related]
5. Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors.
Sudevan ST; Oh JM; Abdelgawad MA; Abourehab MAS; Rangarajan TM; Kumar S; Ahmad I; Patel H; Kim H; Mathew B
Sci Rep; 2022 Dec; 12(1):22404. PubMed ID: 36575270
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors.
Parambi DGT; Oh JM; Baek SC; Lee JP; Tondo AR; Nicolotti O; Kim H; Mathew B
Bioorg Chem; 2019 Dec; 93():103335. PubMed ID: 31606547
[TBL] [Abstract][Full Text] [Related]
7. Identification of Indole-Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO-B Inhibitors.
Sasidharan R; Manju SL; Uçar G; Baysal I; Mathew B
Arch Pharm (Weinheim); 2016 Aug; 349(8):627-37. PubMed ID: 27373997
[TBL] [Abstract][Full Text] [Related]
8. Trimethoxy Crown Chalcones as Multifunctional Class of Monoamine Oxidase Enzyme Inhibitors.
Maliyakkal N; Baysal I; Tengli A; Ucar G; Almoyad MAA; Parambi DGT; Gambacorta N; Nicolotti O; Beeran AA; Mathew B
Comb Chem High Throughput Screen; 2022; 25(8):1314-1326. PubMed ID: 34082669
[TBL] [Abstract][Full Text] [Related]
9. Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors.
Oh JM; Rangarajan TM; Chaudhary R; Singh RP; Singh M; Singh RP; Tondo AR; Gambacorta N; Nicolotti O; Mathew B; Kim H
Molecules; 2020 May; 25(10):. PubMed ID: 32443652
[TBL] [Abstract][Full Text] [Related]
10. Quinolinyl-thienyl chalcones as monoamine oxidase inhibitors and their in silico modeling studies.
Zaib S; Rizvi SU; Aslam S; Ahmad M; Ali Abid SM; Al-Rashida M; Iqbal J
Med Chem; 2015; 11(6):580-9. PubMed ID: 25541744
[TBL] [Abstract][Full Text] [Related]
11. Imidazole bearing chalcones as a new class of monoamine oxidase inhibitors.
Sasidharan R; Baek SC; Sreedharannair Leelabaiamma M; Kim H; Mathew B
Biomed Pharmacother; 2018 Oct; 106():8-13. PubMed ID: 29940538
[TBL] [Abstract][Full Text] [Related]
12. Potent and Selective Monoamine Oxidase-B Inhibitory Activity: Fluoro- vs. Trifluoromethyl-4-hydroxylated Chalcone Derivatives.
Mathew B; Mathew GE; Uçar G; Baysal I; Suresh J; Mathew S; Haridas A; Jayaprakash V
Chem Biodivers; 2016 Aug; 13(8):1046-52. PubMed ID: 27402375
[TBL] [Abstract][Full Text] [Related]
13. Monoamine oxidase inhibitory activity of methoxy-substituted chalcones.
Mathew B; Mathew GE; Ucar G; Joy M; Nafna EK; Lohidakshan KK; Suresh J
Int J Biol Macromol; 2017 Nov; 104(Pt A):1321-1329. PubMed ID: 28577983
[TBL] [Abstract][Full Text] [Related]
14. Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors.
Alagöz MA; Oh JM; Zenni YN; Özdemir Z; Abdelgawad MA; Naguib IA; Ghoneim MM; Gambacorta N; Nicolotti O; Kim H; Mathew B
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744926
[TBL] [Abstract][Full Text] [Related]
15. Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders.
Mathew B; Oh JM; Baty RS; Batiha GE; Parambi DGT; Gambacorta N; Nicolotti O; Kim H
Environ Sci Pollut Res Int; 2021 Aug; 28(29):38855-38866. PubMed ID: 33743158
[TBL] [Abstract][Full Text] [Related]
16. Discovery of potent and reversible MAO-B inhibitors as furanochalcones.
Suresh J; Baek SC; Ramakrishnan SP; Kim H; Mathew B
Int J Biol Macromol; 2018 Mar; 108():660-664. PubMed ID: 29195801
[TBL] [Abstract][Full Text] [Related]
17. Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease.
Reeta ; Baek SC; Lee JP; Rangarajan TM; Ayushee ; Singh RP; Singh M; Mangiatordi GF; Nicolotti O; Kim H; Mathew B
CNS Neurol Disord Drug Targets; 2019; 18(8):643-654. PubMed ID: 31550216
[TBL] [Abstract][Full Text] [Related]
18. Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors.
Mathew B; Haridas A; Uçar G; Baysal I; Adeniyi AA; Soliman ME; Joy M; Mathew GE; Lakshmanan B; Jayaprakash V
Int J Biol Macromol; 2016 Oct; 91():680-95. PubMed ID: 27262516
[TBL] [Abstract][Full Text] [Related]
19. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study.
Thomas Parambi DG; Oh JM; Kumar S; Sudevan ST; Hendawy OM; Abdelgawad MA; Musa A; Al-Sanea MM; Ahmad I; Patel H; Kim H; Mathew B
Comput Biol Chem; 2023 Aug; 105():107899. PubMed ID: 37315342
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of nitrocatechol chalcone and pyrazoline derivatives as inhibitors of catechol-O-methyltransferase and monoamine oxidase.
Hitge R; Smit S; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2020 Jun; 30(12):127188. PubMed ID: 32299731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
